LoQus23
LoQus23 is a small molecule drugs developer for Huntington's disease founded in 2019 by David Reynolds.
2
Funding Rounds
$52.3m
Money raised
Overview
LoQus23 is a small molecule drugs developer for Huntington's disease founded in 2019 by David Reynolds.
- Website:
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Ca****** Be** |
|
- | |
| Da*** Re****** |
|
- |
Funding
Funding series
Funding Series Analysis
The company LoQus23 has raised a total of $52.3m in funding over 2 rounds.
Key Insights:
- LoQus23 Series A Round, October 2024: $43m
- LoQus23 Seed round, November 2021: $9.3m
LoQus23 Series A Round, October 2024
$43m
LoQus23 Seed round, November 2021
$9.3m